Girl Planting seeds

Moderna’s CEO, CMO both sell shares as final coronavirus vaccine trials begin… what do they know that we don’t?

The executive leadership over at Moderna is abandoning ship in terms of what the future holds for its Wuhan coronavirus (COVID-19) vaccine. Both Stéphane Bancel, its CEO, and Tal Zaks, its CMO (chief medical officer) have cashed out their company shares as the company’s plandemic jab is right on the verge of entering late-stage trials. According to Securities and Exchange Commission (SEC) filings, Zaks recently offloaded nearly all of his shares, while Bancel has tossed many of his over the past several months. Zaks, however, still holds tens of thousands of dollars’ worth of options in the company.  Read more....
 

Back

 
 
close (X)